These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1354430

  • 1. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
    Volm M, Mattern J, Efferth T, Pommerenke EW.
    Anticancer Res; 1992; 12(4):1063-7. PubMed ID: 1354430
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cellular predictive factors for the drug response of lung cancer.
    Volm M, Rittgen W.
    Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prediction of drug resistance in human tumors using immunohistochemical techniques.
    Mattern J, Volm M.
    Anticancer Res; 1992; 12(2):413-8. PubMed ID: 1349793
    [Abstract] [Full Text] [Related]

  • 11. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1993 Nov 15; 53(22):5487-93. PubMed ID: 8106148
    [Abstract] [Full Text] [Related]

  • 12. Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer.
    Scagliotti GV, Michelotto F, Kalikatzaros G, Leonardo E, Cappia S, Gubetta L, Borasio P, Pozzi E.
    Anticancer Res; 1991 Nov 15; 11(6):2207-10. PubMed ID: 1685647
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors.
    Efferth T, Mattern J, Volm M.
    Oncology; 1992 Nov 15; 49(5):368-75. PubMed ID: 1356260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of resistance proteins in matched primary lung tumors and lymph node metastases.
    Mattern J, Volm M.
    Anticancer Res; 1994 Nov 15; 14(2A):417-9. PubMed ID: 7912493
    [Abstract] [Full Text] [Related]

  • 18. Expression of drug resistance gene products during progression of lung carcinomas.
    Mattern J, Koomägi R, Volm M.
    Oncol Rep; 2002 Nov 15; 9(6):1181-4. PubMed ID: 12375015
    [Abstract] [Full Text] [Related]

  • 19. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M, Kästel M, Mattern J, Efferth T.
    Cancer; 1993 Jun 15; 71(12):3981-7. PubMed ID: 8099529
    [Abstract] [Full Text] [Related]

  • 20. Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.
    Shin HJ, Lee JS, Hong WK, Shin DM.
    Anticancer Res; 1992 Jun 15; 12(2):367-70. PubMed ID: 1374598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.